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Résumé en
anglais
We propose a regenerative solution in the treatment of critical limb ischaemia (CLI).
Poly-lactic/glycolic acid microcarriers were prepared and coated with laminin to be
sterilized through γ-irradiation of 25 kGy at low temperature. Stromal vascular
fraction (SVF) cells were extracted through enzymatic digestion of adipose tissue.
Streptozotocin-induced diabetic mice underwent arteriotomy and received an
administration of SVF cells combined or not with biomimetic microcarriers.
Functional evaluation of the ischaemic limb was then reported, and tissue
reperfusion was evaluated through fluorescence molecular tomography.
Microcarriers were stable and functional after γ-irradiation until at least 12 months
of storage. Mice that received an injection of SVF cells in the ischaemic limb have
22% of supplementary blood supply within this limb 7 days after surgery compared
with vehicle, whereas no difference was observed at Day 14. With the combined
therapy, the improvement of blood flow is significantly higher compared with vehicle,
of about 31% at Day 7 and of about 11% at Day 14. Injection of SVF cells induces a
significant 27% decrease of necrosis compared with vehicle. This effect is more
important when SVF cells were mixed with biomimetic microcarriers: -37% compared
with control. Although SVF cells injection leads to a non-significant 22%
proprioception recovery, the combined therapy induces a significant recovery of
about 27% compared with vehicle. We show that the combination of SVF cells from
adipose tissue with laminin-coated poly-lactic/glycolic acid microcarriers is efficient
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